This page is part of the FHIR Specification (v4.4.0: R5 Preview #2). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B
Biomedical Research and Regulation Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Not linked to any defined compartments |
Raw JSON (canonical form + also see JSON Format Specification)
Example of medicinalproductdefinition
{ "resourceType": "MedicinalProductDefinition", "id": "example", "text": { "status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative with Details</b></p><p><b>id</b>: example</p><p><b>identifier</b>: {mpid}</p><p><b>productClassification</b>: WHOAnatomicalTherapeuticChemicalATCClassificationSystem|B01AF02 <span>(Details : {http://ema.europa.eu/example/WHOAnatomicalTherapeuticChemicalATCClassificationSystem code 'WHOAnatomicalTherapeuticChemicalATCClassificationSystem|B01AF02' = 'WHOAnatomicalTherapeuticChemicalATCClassificationSystem|B01AF02)</span></p><p><b>attachedDocument</b>: <a>DocumentReference/example</a></p><p><b>masterFile</b>: <a>DocumentReference/example</a></p><blockquote><p><b>name</b></p><p><b>productName</b>: Equilidem 2.5 mg film-coated tablets</p><blockquote><p><b>namePart</b></p><p><b>part</b>: Equilidem</p><p><b>type</b>: INV <span>(Details : {[not stated] code 'INV' = 'INV)</span></p></blockquote><blockquote><p><b>namePart</b></p><p><b>part</b>: 2.5 mg</p><p><b>type</b>: STR <span>(Details : {[not stated] code 'STR' = 'STR)</span></p></blockquote><blockquote><p><b>namePart</b></p><p><b>part</b>: film-coated tablets</p><p><b>type</b>: FRM <span>(Details : {[not stated] code 'FRM' = 'FRM)</span></p></blockquote><h3>CountryLanguages</h3><table><tr><td>-</td><td><b>Country</b></td><td><b>Jurisdiction</b></td><td><b>Language</b></td></tr><tr><td>*</td><td>EU <span>(Details : {http://ema.europa.eu/example/countryCode code 'EU' = 'EU)</span></td><td>EU <span>(Details : {http://ema.europa.eu/example/jurisdictionCode code 'EU' = 'EU)</span></td><td>EN <span>(Details : {http://ema.europa.eu/example/languageCode code 'EN' = 'EN)</span></td></tr></table></blockquote><h3>ManufacturingBusinessOperations</h3><table><tr><td>-</td><td><b>Type</b></td><td><b>EffectiveDate</b></td><td><b>Authorization</b></td></tr><tr><td>*</td><td/><td>2013-03-15 --> (ongoing)</td><td/></tr></table></div>" }, "identifier": [ { "system": "http://ema.europa.eu/example/MPID", "value": "{mpid}" } ], "productClassification": [ { "coding": [ { "system": "http://ema.europa.eu/example/WHOAnatomicalTherapeuticChemicalATCClassificationSystem", "code": "WHOAnatomicalTherapeuticChemicalATCClassificationSystem|B01AF02" } ] } ], "attachedDocument": [ { "reference": "DocumentReference/example" } ], "masterFile": [ { "reference": "DocumentReference/example" } ], "name": [ { "productName": "Equilidem 2.5 mg film-coated tablets", "namePart": [ { "part": "Equilidem", "type": { "coding": [ { "code": "INV" } ] } }, { "part": "2.5 mg", "type": { "coding": [ { "code": "STR" } ] } }, { "part": "film-coated tablets", "type": { "coding": [ { "code": "FRM" } ] } } ], "countryLanguage": [ { "country": { "coding": [ { "system": "http://ema.europa.eu/example/countryCode", "code": "EU" } ] }, "jurisdiction": { "coding": [ { "system": "http://ema.europa.eu/example/jurisdictionCode", "code": "EU" } ] }, "language": { "coding": [ { "system": "http://ema.europa.eu/example/languageCode", "code": "EN" } ] } } ] } ], "manufacturingBusinessOperation": [ { "type": { "concept": { "coding": [ { "system": "http://ema.europa.eu/example/manufacturingOperationType", "code": "Batchrelease" } ] } }, "effectiveDate": { "start": "2013-03-15" }, "authorization": { "identifier": { "system": "http://ema.europa.eu/example/manufacturingAuthorisationReferenceNumber", "value": "1324TZ" } } } ] }
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.